Hepatitis B surface antigen in a patient’s serum indicates that the patient is:
**Core Concept**
Hepatitis B surface antigen (HBsAg) is a protein on the surface of the hepatitis B virus (HBV) that is used as a marker for the presence of the virus in the body. The presence of HBsAg in a patient's serum indicates an active HBV infection.
**Why the Correct Answer is Right**
The presence of HBsAg suggests that the patient is in the infectious window phase of HBV infection, where the virus is actively replicating and the patient is capable of transmitting the virus to others. This is because HBsAg is present on the surface of the virus particles and is released into the bloodstream as the virus replicates. The detection of HBsAg is a critical diagnostic marker for chronic and acute HBV infection.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because HBsAg is not a marker for hepatitis A virus (HAV) infection, which is a different type of viral hepatitis.
**Option B:** This option is incorrect because anti-HBs (antibody to hepatitis B surface antigen) is a marker of immunity to HBV, either through vaccination or past infection, and is not a marker of active infection.
**Option C:** This option is incorrect because anti-HBc (antibody to hepatitis B core antigen) is a marker of current or past HBV infection, but it does not distinguish between chronic and acute infection.
**Clinical Pearl / High-Yield Fact**
It's essential to note that the presence of HBsAg in a patient's serum indicates a need for further testing, including liver function tests, HBV DNA levels, and liver imaging studies, to determine the extent of liver damage and guide treatment decisions.
**Correct Answer: C. The patient is in the infectious window phase of HBV infection.**